Agilent Technologies Inc. (NYSE:A) shares rose 4% on Thursday after the laboratory technologies company delivered stronger-than-expected fiscal third-quarter revenue and raised its full-year outlook.
Revenue reached $1.74 billion, ahead of the $1.67 billion estimate and up 10.1% year-over-year. Adjusted earnings per share were $1.37, in line with consensus. The results marked Agilent’s fifth consecutive quarter of sequential core-revenue acceleration.
By segment, the Life Sciences and Diagnostics Group grew 14% to $670 million, the Agilent CrossLab Group rose 8% to $744 million, and the Applied Markets Group increased 7% to $324 million.
For FY26, Agilent now expects revenue of $6.91 billion to $6.93 billion, representing growth of 6.2% to 6.5%, up from prior guidance. Fourth-quarter revenue was guided at $1.822 billion to $1.842 billion, well above the $1.75 billion consensus, with adjusted EPS projected at $1.57 to $1.60.
